USFDA imposes import alert on Sun Pharma’s Gujarat plant

13 Mar 2014 Evaluate

The United States Food and Drug Administration (US FDA) has imposed an import alert, effectively a ban, on generic drug-maker Sun Pharmaceutical Industries’ plant in Gujarat. The plant at Karkhadi in Gujarat makes both drug ingredients and formulations.

An ‘import alert’ results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices.

Recently, the company’s subsidiary Caraco received US FDA approval for Risperidone oral tablets. The oral tablet is used for the treatment of schizophrenia (a mental disorder).

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1634.40 21.85 (1.35%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×